Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development

Abstract

Increased regulatory demands for pediatric drug development research have fostered interest in the use of modeling and simulation among industry and academia. Physiologically based pharmacokinetic (PBPK) modeling offers a unique modality to incorporate multiple levels of information to estimate age‐specific pharmacokinetics. This tutorial will serve to provide the reader with a basic understanding of the procedural steps to developing a pediatric PBPK model and facilitate a discussion of the advantages and limitations of this modeling technique. CPT Pharmacometrics Syst. Pharmacol. (2014) 3, e148; doi:10.1038/psp.2014.45; published online 19 November 2014